Role of transforming growth factor beta in the regulation of thyroid function and growth

Thyroid

Volumn 19, Issue 8, 2009, Pages 881-892

  Pisarev, Mario A ^a   Thomasz, Lisa ^a   Juvenal, Guillermo J ^a  

^a DEPARTAMENTO DE FÍSICA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; IODINE; ISOPROTEIN; MESSENGER RNA; SMAD2 PROTEIN; SMAD3 PROTEIN; SODIUM IODIDE SYMPORTER; THYROGLOBULIN; THYROID PEROXIDASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; AUTOREGULATION; CELL MEMBRANE; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SWINE; THYROID CANCER; THYROID DISEASE; THYROID FOLLICLE; THYROID FUNCTION; TRANSCRIPTION REGULATION;

ANIMALS; CELL PROLIFERATION; CYCLIC AMP; DOGS; GENE EXPRESSION REGULATION; HUMANS; IODINE; PHOSPHORYLATION; PROTEIN ISOFORMS; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SWINE; THYROID GLAND; TRANSFORMING GROWTH FACTOR BETA;

EID: 68349118960     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0303     Document Type: Review

References (106)

1. ten Dijke P, Hill CS 2004 New insights into TGF-β-Smad signalling. Trends Biochem Sci 29:265-273.
2. Massagué J, Gomis RR 2006 The logic of TGF-β signalling. FEBS Lett 580:2811-2820.
3. Cosgaya JM, Aranda A 1995 Nerve growth factor regulates transforming growth factor-β1 expression by both transcriptional and posttranscriptional mechanism in PC 12 cells. J Neurochem 65:2484-2490.
4. Danielpour D 1996 Induction of transforming growth factor-β autocrine activity by all-trans-retinoic acid and 1-ά, 25-dihydroxy-vitamin D3, in NRP-152 rat prostatic epithelial cells. J Cell Physiol 166:231-239.
5. Arrick BA, Korc M, Derynck R 1990 Differential regulation expression of three transforming growth factor β species in human breast cancer cell lines by estradiol. Cancer Res 50: 299-303. (Pubitemid 20041231)
6. Bonewald LF, Oreffo ROC, Lee CH, Park-Snyder S, Tawardzik D, Mundy GR 1997 Effects of retinol on activation of latent transforming growth factor-β by isolated osteoclasts. Endocrinology 138:657-666. (Pubitemid 27110916)
7. Vodovotz Y, Chesler L, Chong H, Kim SJ, Simpson JT, DeGraff W, Cox GW, Roberts AB, Wink DA, Barcellos-Hoff MH 1999 Regulation of transforming growth factor β1 by nitric oxide. Cancer Res 59:2142-2149. (Pubitemid 29217678)
8. Massague J, Seoane J, Wotton D 2005 Smad transcription factors. Genes Dev 19:2783-2810.
9. Moustakas A, Heldin CH 2005 Non-Smad TGF-beta signals. J Cell Sci 118:3573-3584.
10. Derynck R, Zhang YE 2003 Smad-dependent and Smadindependent pathways in TGF-beta family signalling. Nature 425:577-584. (Pubitemid 37280136)
11. Li DM, Sun H 1997 TEP1 encoded by a candidate tumor suppressor locus is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 57:2124-2129. (Pubitemid 27247025)
12. Bierie B, Moses HL 2006 Tumor microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6:506-520. (Pubitemid 43980540)
13. Stover DG, Brierie B, Moses HL 2007 A delicate balance: TGF-β and the tumor microenvironment. J Cell Biochem 101:851-861.
14. Sansal I, Sellers WR 2004 The biology and clinical relevance of the PTEN suppressor pathway. J Clin Oncol 22: 2954-2963. (Pubitemid 41079915)
15. Bodganowicz P, Pujol JP 2000 Glycosylphosphatidylinositol (GPI) hydrolysis by transforming growth factorbeta (TGF-β1) as a potential early step in the inhibition of epithelial cell proliferation. Mol Cell Biochem 208:143-160.
16. Seoane J 2006 Escaping from TGF-β anti-proliferative control. Carcinogenesis 27:2148-2156.
17. Vujaskovic Z, Marks LB, Anscher MS 2000 The physical parameters and molecular events associated with radiationinduced lung toxicity. Semin Radiat Oncol 10:296-307. (Pubitemid 30783110)
18. Li C, Wilson PB, Levine E, Barber J, Stewart AL, Kumar S 1999 TGF-beta 1 levels in pre-treatment plasma identify breast cancer patients at risk of developing postradiotherapy fibrosis. Int J Cancer 84:155-159. (Pubitemid 29133827)
19. Anscher MS, Thrasher B, Rabbani Z, Teicher B, Vujaskovic Z 2006 Antitransforming growth factor-β antibody 1D11 ameliorates normal tissue damage caused by high-dose radiation. Int J Radiat Oncol Biol Phys 65:876-881. (Pubitemid 43795819)
20. Pisarev MA, Gärtner R 2000 Autoregulatory action of iodine. In: Braverman LE, Uitger RD (eds) The Thyroid, 8th edition. Lippincott, Philadelphia/New York, pp 85-90.
21. Yuasa R, Eggo MC, Meinkoth J, Dillmann WH, Gurrow GN 1992 Iodide induces transforming growth factor beta1 mRNA in sheep thyroid cells. Thyroid 2:141-145.
22. Cowin AJ, Bidey SP 1995 Porcine thyroid follicular cells in monolayer culture the iodide-responsive precursor form of transforming growth factor-beta 1. J Endocrinol 144:67-73.
23. Cowin AJ, Davis JRE, Bidey SP 1992 Transforming growth factor β1 production in porcine thyroid follicular cells: regulation by intrathyroidal organic iodine. J Mol Endocrinol 9:197-205.
24. Dugrillon A, Uedelhoven WM, Pisarev MA, Bechtner G, Gartner R 1994 Identification of delta-iodolactone in the extract of iodide treated human goiter and its inhibitory effect on the proliferation of human thyroid follicles. Horm Metab Res 26:465-469. (Pubitemid 2161108)
25. Gartner R, Schopohl D, Schaefer S, Dugrillon A, Erdmann A, Toda S, Bechtner G 1997 Regulation of transforming growth factor β1 messenger ribonucleic acid expression in porcine thyroid follicles in vitro by growth factors, iodine and delta-iodolactone. Thyroid 7:633-640. (Pubitemid 27371805)
26. Cowin AJ, Heaton EI, Cheshire SH, Bidey SP 1996 The proliferative responses of porcine thyroid follicular cells to epidermal growth factor and thyrotrophin reflect the autocrine production of transforming growth factor-β1. J Endocrinol 148:87-94.
27. Grubeck Loebenstein B, Buchan G, Kissonerghis M, Londei M, Turner M, Pirich K, Roka R, Niederle B, Kassal H, Walhaust W, Feldmann M 1989 Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of non-toxic goiter. J Clin Invest 8:764-770. (Pubitemid 19080603)
28. Morosini PP, Toccaliti A, Arnaldi G, Siimonella G, Pretelli MD, Montironi R, Scarpellli M, Diamanti L, Montero F 1996 Enhanced expression of transforming growth factor beta 1 in rat thyroid hyperplasia is thyrotropin induced and time dependent. Eur J Endocrinol 134:373-378. (Pubitemid 26108156)
29. Logan A, Smith C, Becks GP, Gonzalez AM, Phillips ID, Hill DJ 1994 Enhanced expression of transforming growth factor-β1 during thyroid hyperplasia in rats. J Endocrinol 141:45-57. (Pubitemid 24141976)
30. Kolaja KL, Hood AM, Klaassen CD 1999 The UDP-glucuronyltransferase inducers, Phenobarbital and pregnenolone- 16α-carbonitrile, enhance thyroid follicular cell apoptosis associated with TGF-β1 expression. Toxicol Lett 106:143-150.
31. Roger PP 1996 Thyrotropin-dependent transforming growth factor beta expression in thyroid gland. Eur J Endocrinol 134:269-271. (Pubitemid 26108145)
32. Carneiro C, Alvarez CV, Zaldive J, Vidal A, Dominguez F 1988 TGF-β1 action on FRTL-5 cells provide a model for the physiologic regulation of thyroid growth. Oncogene 16: 1455-1465.
33. Cirafaci AM, Pepe S, Mincione G, Esposito D, Colletta G 1992 TGF-beta inhibits rat thyroid cell proliferation without alterations in the expression of TSH-induced cell-cycle related genes. Bioochem Biophys Res Commun 187:225-233.
34. Nicolussi A, D'Inzeo S, Gismondi A, Coppa A 2006 Reduction of invasive potential in K-ras-transformed thyroid cells by restoring of TGF-β pathway. Clin Exp Metastasis 23:237-248. (Pubitemid 44777564)
35. Depoortere F, Pirson I, Bartek J, Dumont JE, Roger PP 2000 Transforming growth factor beta 1 selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3- cdk4 with nuclear p27(kip1). Mol Biol Cell 11:1061-1076. (Pubitemid 30159322)
36. Coulonval K, Bockstaele L, Paternot S, Dumont JE, Roger PP 2003 The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGF-β and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis. Exp Cell Res 291: 135-149. (Pubitemid 37338688)
37. Franzen A, Pick E, Westermeark B, ten Dijke P, Heldin NE 1999 Expression of transforming growth factor-beta1, activin A and their receptors in thyroid follicle cells: negative regulation of thyroid growth and function. Endocrinology 140:4300-4310. (Pubitemid 30647129)
38. Beere HM, Soden J, Tomlinson S, Bidey SP 1991 Insulin-like growth factor-I production and action in porcine thyroid follicular cells in monolayer: regulation by transforming growth factor-beta. J Endocrinol 130:3-9.
39. Mincione G, Esposito DL, Marcantonio MC, Piccirelli A, Cama A, Coletta G 2003 TGF-β 1 modulation of IGF-I signalling pathway in rat thyroid epithelial cells. Exp Cell Res 287:411-423. (Pubitemid 37323852)
40. Liu G, Takano T, Amino N 1996 TGF-beta 1 inhibits the cell proliferation stimulated by IGF-1 by blocking the tyrosine phosphorylation of 175kDa substrate. Endocr Res 22:277-287. (Pubitemid 26299750)
41. Nilsson M, Dahlman T, Westermark B, Westermark K 1995 Transforming growth factor-beta promotes epidermal growth factor-induced thyroid cell migration and follicle neoformation in collagen gel separable from cell proliferation. Exp Cell Res 220:257-265.
42. Grande M, Franzen A, Karlsson JO, Ericson LE, Heldin NE, Nilsson M 2002 Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. J Cell Sci 115:4227-4236. (Pubitemid 35460694)
43. Toda S, Matsumura S, Fujitani N, Nishimiura T, Yonemitsu N, Sugihara H 1997 Transforming growth factor beta-1 induces a mesenchymal-like cell shape without epithelial polarization in thyrocytes and inhibits thyroid folliculogenesis in collagen cell culture. Endocrinology 138:5561-5575. (Pubitemid 27509723)
44. Bechtner G, Froschl H, Sachse A, Shopohl D, Gartner R 1999 Induction of apoptosis in porcine thyroid follicles by transforming growth factor beta 1 and epidermal growth factor. Biochimie 8:315-320.
45. Bravo SB, Pampin S, Cameselle-Teijeiro J, Carneiro C, Dominguez F, Barreiro F, Alvarez CV 2003 TGF-β induced apoptosis in human thyrocytes is mediated by p27 kip1 reduction and overridden in neoplasic thyrocytes by NFkB activation. Oncogene 22:7819-7830. (Pubitemid 37485541)
46. Lehmann P, Rank P, Hallfeldt KL, Krebs B, Gartner R 2006 Dose-related influence of sodium selenite on apoptosis in human thyroid follicles in vitro induced by iodine, EGF, TGF-β and H2O2. Biol Trace Elem Res 112:119-130. (Pubitemid 44544190)
47. Claisse D, Martiny I, Chaqour B, Wegrowski Y, Petitfrere E, Schneider C, Haye B, Bellon G 1999 Influence of transforming growth factor beta1 (TGF-β1) on the behaviour of porcine thyroid epithelial cells in primary culture through thrombospondin-1 synthesis. J Cell Sci 112:1405-1416. (Pubitemid 29243463)
48. Kotlarz G, Wegrowski Y, Martiny L, Declerck DJ, Bellon G 2002 Enhanced expression of plasminogen activator inhibitor-1 by dedifferentiation thyrocytes. Biochem Biophys Res Commun 295:735-743. (Pubitemid 34756911)
49. Delorme N, Remond C, Sartelet H, Petitfrère E, Clément C, Schneider C, Bellon G, Virion A, Haye B, Martiny E 2002 TGF-β1 Effects on functional activity of porcine thyroid cells cultured in suspension. J Endocrinol 173:345-355.
50. Taton M, Lamy F, Roger PP, Dumont JE 1993 General inhibition by transforming growth factor β1 of thyrotropin and cAMP responses in human thyroid cells in primary culture. Mol Cell Endocrinol 95:13-21. (Pubitemid 23267191)
51. Pang XP, Park M, Hershman JM 1992 Transforming growth factor-β blocks protein-kinase-A-mediated iodide transport and protein-kinase-C mediated DNA synthesis in FRTL-5 rat thyroid cells. Endocrinology 131:45-50.
52. Coletta G, Cirafaci AM, Di Carlo A 1989 Dual effect of transforming growth factor β on rat thyroid cells: inhibition of thyrotropin-induced proliferation and reduction in thyroidspecific differentiation markers. Cancer Res 49:3457-3462. (Pubitemid 19178158)
53. Tsushima T, Arai M, Saji M, Ohba Y, Murakami H, Ohmura E, Sato K, Shizume K 1988 Effects of TGF-β on DNA synthesis and iodine metabolism in porcine thyroid cells in culture. Endocrinology 123:1187-1194.
54. Nicolussi A, D'Inzeo S, Santulli M, Coletta G, Coppa A 2003 TGF-beta control of thyroid follicular cells differentiation. Mol Cell Endocrinol 207:1-11. (Pubitemid 37102948)
55. Coppa A, Mincione G, Mammarella S, Ranieri A, Colletta G 1995 Epithelial rat thyroid cell clones, escaping from transforming growth factor beta negative growth control, are still inhibited by this factor in the ability to trap iodide. Cell Growth Differ 6:281-290.
56. - symporter messenger RNA and protein levels in FRTL-5 rat thyroid cells. Thyroid 7:789-794.
57. - symporter messenger ribonucleic acid levels in FRTL-5 cells. Endocrinology 139:703-712.
58. +- ATPase in FRTL-5 rat thyroid cells. J Interferon Cytokine Res 17:185-195.
59. Costamagna E, Garcia B, Santisteban P 2004 The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-β repression of the sodium=iodide symporter gene. J Biol Chem 279:3439-3446. (Pubitemid 38140582)
60. Kang HC,Ohmori M, Harii N, Endo T,Onaya T 2001 Pax-8 is essential for regulation of the thyroglobulin gene by transforming growth factor-beta1. Endocrinology 142:267-275. (Pubitemid 32183688)
61. Bechtner G, Winter H, Greil W, Gartner R 1990 Effects of transforming growth factor beta on growth, iodine metabolism and cAMP formation in porcine thyroid follicles in culture. In: Drexhage HA, de Vijlder JJM, Wiersinga WM (eds). The Thyroid Gland Environment and Autoimmunity. Elsevier, Holland, pp 157-160.
62. Matsumura M, Banba N, Motohashi S, Hattori Y 1999 Interleukin-6 and transforming growth factor-beta regulate the expression of monocyte chemoattractant protein-1 and colony-stimulating factors in human thyroid follicular cells. Life Sci 65:PL129-PL135. (Pubitemid 29425969)
63. Tseng YCL, Lahiri S, Jackson S, Burdman KD, Wartofsky L 1993 Endothelin binding to receptors and endothelin production by human thyroid follicular cells: effects of transforming growth factor-β and thyrotropin. J Clin Endocrinol Metab 76:156-161. (Pubitemid 23027571)
64. Napolitano G, Montani V, Giuliani C, Di Vincenzo S, Bucci I, Todisco V, Laglia G, Coppa A, Singer DS, Nakazato M, Kohn LD, Colletta G, Monaco F 2000 Transforming growth factor-beta 1 down-regulation of major histocompatibility complex class I in thyrocytes: coordinate regulation of two separate elements by thyroid-specific as well as ubiquitous transcription factors. Mol Endocrinol 14:486-505. (Pubitemid 32260519)
65. Wegrowski Y, Perreau C, Martiny L, Haye B, Maquart FX, Bellon G 1999 Transforming growth factor beta-1 upregulates clusterin synthesis in thyroid epithelial cells. Exp Cell Res 247:475-483. (Pubitemid 29394785)
66. Garbi C, Colletta G, Cirafaci AM, Marchisio PC, Nitsch L 1990 Transforming growth factor-beta induces cytoskeleton and extracellular matrix modifications in FRTL-5 thyroid epithelial cells. Eur J Cell Biol 53:281-289.
67. Huang SA, Mulcahey MA, Crescenzi A, Chung M, Kim BW, Barnes C, Kuijt W, Turano H, Harnery J, Larsen PR 2005 Transforming growth factor-beta promotes inactivation of extracellular thyroid hormones via transcriptional stimulation of type 3 iodothyronine deiodinase. Mol Endocrinol 19:3126-3136. (Pubitemid 41697726)
68. Yen CC, Huang YH, Liao CY, Cheng WL, Chen WJ, Lin KH 2006 Mediation pf the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-beta. J Mol Endocrinol 36:9-21.
69. Lin KH, Chen CY, Chen CC, Huang YH, Shih CH, Shen JJ, Yang RC, Wang CS 2004 Regulation of fibronectin by thyroid hormone receptors. J Mol Endocrinol 33:445-458. (Pubitemid 39429568)
70. Mello MA, Tuan RS 2006 Effects of TGF-beta 1 and triiodothyronine on cartilage maturation: in vitro analysis using long-term high-density micromass cultures of chick embryonic limb mesenchymal cells. J Orthop Res 24:2095-2105.
71. Diniz GP, Carneiro-Ramos MS, Barreto-Chaves ML 2007 Angiotensin type 1 (AT1) and type 2 (AT2) receptors mediate the increase in TGF-beta 1 in thyroid hormoneinduced cardiac hypertrophy. Pflugers Arch 454:75-81.
72. Eszlinger M, Krohn K, Kratzsch J, Voigt C, Paschke R 2001 Growth factor expression in cold and hot thyroid nodules. Thyroid 11:125-135. (Pubitemid 32221035)
73. Morosini P, Toccaliti A, Di Loreto C, Arnaldi G, Giacchetti G, Mantero F 1994 Transforming growth factor β1 mRNA is more expressed in thyroid follicular adenoma than in normal tissue. J Endocrinol Invest 17:335-340.
74. Morosini PP, Toccaliti A, Montironi R, Scarpelli M, Diamati L, Simonella G, Mancini V, PetrelliMD, Mantero F 1996 TGF-β1 immunohistochemistry in goiter: comparison of patients with recurrence or no recurrence. Thyroid 6:417-422. (Pubitemid 26398646)
75. Eszlinger H, Krohn K, Frenzel R, Kroof S, Tonjes A, Paschke R 2004 Gene expression analysis revels evidence for inactivation of the TGF-beta signalling cascade in autonomously functioning thyroid nodules. Oncogene 23: 795-804. (Pubitemid 38241280)
76. Kimura ET, Kopp P, Zbaeren J, Asmis LM, Ruchti C, Maciel RMB, Studer H 1999 Expression of transforming growth factor β1, β2 and β3 in multinodular goiters and differentiated thyroid carcinomas: a comparative study. Thyroid 9:119-125.
77. Brzozowska M, Kinalska I, Kretowwski A 2005 The level of IGF-1 and TGF-beta1 in the blood and the thyroid size in children with normal ioduria. Endokrinol Diabetol Chor Przemiany Materii Wieku Rozw 11:215-220. (Pubitemid 41499374)
78. Mincioni G, Cirafaci AM, Lazzareschi D, Pepe S, Ciardiello F, Colletta G 1993 Loss of thyrotropin regulation and transforming growth factor beta-induced growth arrest in erbB-2 overexpressing rat thyroid cells. Cancer Res 53:5548-5553. (Pubitemid 23342182)
79. Vesely D, Astl J, Lastuvka P, Matucha P, Sterzl I, Betka J 2004 Serum levels of IGF-I, HGF, TGF-beta 1, bFGF and VEGF in thyroid gland tumors. Physiol Res 53:83-89. (Pubitemid 38295545)
80. Vasko V, Espinosa AV, Scouten W, He H, Auer H, Liyanarachchi S, Larin A, Savchenko V, Francis GL, de la Chapelle A, Saji M, Ringel MD 2007 Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci USA 104:2803-2808. (Pubitemid 46327960)
81. Imamura Y, Jin L, Grande JP, Li CY, Zheng TR, Erickson LA, Lloyd RV 1998 Analysis of TGF-B and TGF-B-RII in thyroid neoplasms from the United States, Japan and China. Endocr Pathol 9:209-216.
82. Lazzareschi D, Rainieri A, Mincioni G, Taccogna S, Nardi F, Coletta G 1997 Human malignant thyroid tumors displayed reduced levels of transforming growth factor beta receptor type II messenger RNA and protein. Cancer Res 57:2071-2076. (Pubitemid 27209743)
83. Matoba H, Sugano S, Yamaguchi N, Miyachi Y 1998 Expression of transforming growth factor beta 1 and transforming growth factor beta type II receptor mRNA in papillary thyroid carcinoma. Horm Metab Res 30:624-628. (Pubitemid 28523425)
84. Turco A, Coppa A, Aloe S, Baccherschi G, Morrone S, Zupi G, Colletta G 1999 Overexpression of transforming growth factor beta-type II receptor reduces tumorigenesis and metastatic potential of K-ras-transformed thyroid cells. Int J Cancer 80:85-91. (Pubitemid 28559782)
85. Motti ML, Califano D, Troncone G, de Marco C, Migliaccio I, Palmieri E, Pezzullo L, Palombini L, Fusco A, Viglietto G 2005 Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K-AKT pathway. Am J Pathol 166:737-749.
86. Lazzareschi D, Nardi F, Turco A, Ottini L, D'Amico C, Mariani-Costantini R, Gulino A, Coppa A 2005 A complex pattern of mutations and abnormal splicing of Smad4 is present in thyroid tumors. Oncogene 24:5344-5354. (Pubitemid 43080104)
87. Schulte KM, Jonas C, Krebs R, Roher HD 2001 Activin A and activin receptors in thyroid cancer. Thyroid 11:3-14.
88. Holting T, Zielke A, Siperstein AE, Clark OH, Duh QY 1994 Transforming growth factor β1 is a negative regulator for differentiated thyroid cancer: studies of growth, migration, invasion and adhesion of cultured follicular and papillary thyroid cancer cell lines. J Clin Endocrinol Metab 78:806-813. (Pubitemid 24286407)
89. Matsuo SE, Leoni SG, Colquhoun A, Kimura ET 2006 Transforming growth factor beta-1 and activin A generate antiproliferative signaling in thyroid cancer cells. J Endocrinol 190:141-150. (Pubitemid 44161069)
90. Heldin NE, Bergstrom D, Hermansson A, Bergestrahle A, Nakao A, Westermark B, ten Dijke P 1999 Lack of responsiveness to TGF-β1 in a thyroid carcinoma cell line with a functional type I and type II TGF-β receptors and Smad proteins, suggests a novel mechanism for TGF-β insensitivity in carcinoma cells. Mol Cell Endocrinol 153:79-90. (Pubitemid 29339159)
91. Lindkvist A, Franzen A, Ren ZP, Heldin NE, Paulsson- Karlsson Y 2005 Differential effects of TGF-beta1 on telomerase activity in thyroid carcinoma cell lines. Biochem Biophys Res Commun 338:1625-1633. (Pubitemid 41608436)
92. Wyllie FS, Dawson T, Bond JA, Goretzki P, Game S, Prime S, Wynford-Thomas D 1991 Correlated abnormalities of transforming growth factor-beta 1 response and p53 expression in thyroid epithelial cell transformation. Mol Cell Endocrinol 76:13-21.
93. Blaydes JP, Schlumberger M, Wynford-Thomas S, Wyllies FS 1995 Interaction between p53 and TGF-β1 in control of epithelial proliferation. Oncogene 10:307-317.
94. Pacifico F, Paolillo M, Chiappetto G, Crescenzi E, Arena S, Scaloni A, Monaco M, Vascotto C, Tell G, Formisano S, Leonardi A 2007 RbAp48 is a target of nuclear factor-kB Activity in thyroid cancer. JClin EndocrinolMetab 92:1458-1466. (Pubitemid 46556426)
95. Franzen A, Heldin NE 2001 BMP-7-induced cell cycle arrest of anaplastic thyroid carcinoma cells via p21(CIP-1) and p27(Kip-1) Biochem Biophys Res Commun 285:773-781. (Pubitemid 32924836)
96. Lammerts E, Roswall P, Sundberg C, Gotwals PJ, Kotellansky VE, Reed RK, Heldin NE, Rubin K 2002 Interference with TGF-beta1 and beta3 in tumor stroma lowers tumor interstitial fluid pressure independently of growth in experimental carcinoma. Int J Cancer 102:453-462. (Pubitemid 35315998)
97. van Staveren W, Weiss Solis D, Delys L, Duprez L, Andry G, Franc B, Thomas T, Libert F, Dumont JE, Detours V, Maenhaut C 2007 Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype. Cancer Res 67:8113-8120. (Pubitemid 47395146)
98. Matsumura M, Banba N, Motohashi S, Hattori Y 1999 Interleukin- 6 and transforming growth factor-beta regulate the expression of monocyte chemoattactant protein-1 and colony-stimulating factors in human follicular cells. Life Sci 65:PL129-PL135. (Pubitemid 29425969)
99. Chen K, Wel Y, Sharp GC, Braley-Mullen H 2000 Characterization of thyroid fibrosis in a murine model of granulomatous experimental autoimmune thyroiditis. J Leukoc Biol 68:828-835.
100. Chen K, Wel Y, Sharp GC, Braley-Mullen H 2002 Inhibition of TGFbeta1 by anti-TGF beta1 antibody or lisinopril reduces thyroid fibrosis in granulomatous experimental autoimmune thyroiditis. J Immunol 169:6530-6538. (Pubitemid 36903505)
101. Toda S, Nishimura T, Yamada S, Kolke N, Yonemitsu N, Watanabe K, Matsumura S, Gartner R, Sugihara H 1999 Immunohistochemical expression of growth factors in subacute thyroiditis and their effects on thyroid folliculogenesis and angiogenesis in collagen matrix culture. J Pathol 188:415-422. (Pubitemid 29327441)
102. Contempre B, Le Moine O, Dumont JE, Denef JF, Many MC 1996 Selenium deficiency and thyroid fibrosis. A key role for macrophages and transforming growth factor beta (TGF-beta). Mol Cell Endocrinol 124:7-15.
103. Olivieri A, de Angelis S, Vaccari V, Valensise H, Magnani F, Satzi MA, Cotichini R, Gilardi E, Cordeddu V, Sorcini M, Boirivant M 2003 Postpartum thyroiditis is associated with fluctuations in transforming growth factor-beta 1 serum levels. J Clin Endocrinol Metab 88:1280-1284. (Pubitemid 36337790)
104. Mysliwiec J, Kretowski A, Stepien A, Mironczuk K, Kinalska I 2003 Interleukin 18 and transforming growth factor beta1 in the serum of patients with Graves' ophthalmopathy treated with corticosteroids. Int Immunopharmacol 3:549-552. (Pubitemid 36419515)
105. Marazuela M, Garcia-Lopez MA, Figueroa-Vega N, de la Fuente H, Alvarado-Sanchez B, Monsivais-Urenda A, Sanchez-Madrid F, Gonzalez-Amaro R 2006 Regulatory T cells in human autoimmune disease. J Clin Endocrinol Metab 91:3639-3646. (Pubitemid 44402149)
106. Corica F, Allegra A, Buemi M, Rubino F, Bonanzinga S, Ruello A, Ceruso D 1998 Increased transforming growth factor β1 plasma concentration is associated with high plasma 3,30,50-triiodothyronine in elderly patients with nonthyroidal illnesses. Eur J Endocrinol 138:47-50. (Pubitemid 28078808)